News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
166 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19613)
Month
January (3339)
February (3294)
March (4068)
April (3456)
May (4782)
June (3455)
July (2689)
August (3589)
September (3334)
October (3976)
November (4082)
December (2500)
Day
1 (180)
2 (200)
3 (92)
4 (2)
5 (1)
6 (166)
7 (207)
8 (176)
9 (168)
10 (69)
11 (2)
12 (2)
13 (142)
14 (189)
15 (157)
16 (198)
17 (60)
18 (4)
19 (6)
20 (36)
21 (216)
22 (182)
23 (237)
24 (83)
25 (1)
26 (4)
27 (226)
28 (288)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Lone Star Bio
AnX Robotica Commences Launch of the NaviCam® Small Bowel System
AnX Robotica Corporation (www.anxrobotics.com), the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce the launch of the NaviCam Small Bowel System in the United States.
February 6, 2023
·
1 min read
Drug Development
Carina Biotech to Present Preclinical Data at Lorne Cancer 2023 Supporting Effectiveness of LGR5-Targeted CAR-T Cell Therapy Platform in Ovarian Cancer Tumor Models
Carina Biotech Pty Ltd (Carina), a cell therapy immuno-oncology company, today announced that a poster presentation with preclinical data supporting the effectiveness of its LGR5-targeted CAR-T platform in ovarian cancer cell models will be presented at the 35th Annual Lorne Cancer Conference.
February 6, 2023
·
2 min read
Pharm Country
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract InclusionsResearch highlights the significance and clinical relevance of portable MRI technology
Hyperfine, Inc., creator of the Swoop® Point-of-Care MRI System™ for imaging of the brain, today announced the acceptance of twelve abstracts related to the Swoop® system to be presented at the prestigious International Society for Magnetic Resonance in Medicine (ISMRM) and International Society of MR Radiologist and Technologists (ISMRT) annual meeting.
February 6, 2023
·
6 min read
Drug Development
Phase II Study of Orelabrutinib in Patients with R/R CLL/SLL Published by American Journal of Hematology
American Journal of Hematology recently published the phase 2 study result of BTK inhibitor orelabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma patients.
February 6, 2023
·
4 min read
KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya
The Kenya Medical Research Institute, NEC Corporation and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.
February 6, 2023
·
2 min read
J INTS BIO, Oral TKI ‘JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC
J INTS BIO announced that the preclinical results of “JIN-A04,” a novel oral tyrosine kinase inhibitor targeting HER2 Exon20 insertion mutation in NSCLC, will be presented at the upcoming 2023 American Cancer Research Association meeting in Orlando, U.S. from April 14 to 19.
February 6, 2023
·
1 min read
Previous
17 of 17